Oldcastle BuildingEnvelope®, Inc has sold Antamex International, Inc. to O3 Industries LLC
Oldcastle BuildingEnvelope®, Inc. (Oldcastle) has sold its Toronto-based fenestration subcontracting business unit, Antamex International, Inc. (Antamex), to O3 Industries LLC.
Antamex is a provider of custom high-performance unitized glass façade solutions and engineering design services for commercial, institutional, high-end residential and mixed-use projects across North America.
O3 Industries is a private investment firm based in New York City.
Oldcastle, part of the Building Products Division of CRH plc (ISE:CRG), is a premier supplier of glazing-focused interior and exterior products, including architectural glass, metal, engineered systems and glazing hardware and supplies.
One of Oaklins’ teams in the USA served as the exclusive financial advisor to the seller in this transaction.


Talk to the deal team
Jerome S. Romano
Oaklins TM Capital
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more